September 16, 2024

Supplementary Figure S6 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Univariable analyses of association of clinical characteristics with long-term response (LTR) compared to short-term response (STR), non-LTR, and progressive disease (PD).

Preguntar a la IA

Me gusta

Guardar

Cite This Study

Thummalapalli et al. (Mon,) studied this question.

synapsesocial.com/papers/68e586c1b6db643587523978 https://doi.org/https://doi.org/10.1158/1078-0432.27033028

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S6 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer2024
2Supplementary Figure S1 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer2024
3Supplementary Figure S1 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer2024
4Supplementary Figure S11 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer2024
5Supplementary Figure S11 from Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer2024

Preguntar a la IA

Me gusta

Guardar